Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 16498.72 340.44 NIFTY 4898.40 102.25

Cipla

BSE: 500087  |  NSE: CIPLA  |  ISIN: INE059A01026  |  Pharmaceuticals
    
 

Have a tip or information to share on Cipla?


Message   Positive opinion   Negative opinion   Query   Grievance   
View by : 
Latest Messages   |   Most Active   |   Top Rated   |   Top Tracked   |   Active Boarders
Go to page:   1    2    3    4    5    6    Next  [  ]    
Sort by:   
Positive Opinions   |   Negative Opinions   |   Queries   |   Grievances   |   ALL
07 Nov 2009 21:24

Heading

Posted by : naugtyboy
Price when posted : BSE: Rs 291.85 ( -0.36 % ), NSE: Rs. 291.65 ( -0.61 % )

share will be rangebound between 265-302-if above 305 for few days then 350 will be fast achieved...

07 Nov 2009 13:41

Buy

Posted by : lmj
Price when posted : BSE: Rs 291.85 ( -0.36 % ), NSE: Rs. 291.65 ( -0.61 % )

Good Working ...

31 Oct 2009 11:05

CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS

Posted by : ar_akm
Price when posted : BSE: Rs 287.75 ( -1.05 % ), NSE: Rs. 287.10 ( -0.97 % )

Hi scorpio76, Best work done. Updation is needed to stay in the market. Thanks!...

30 Oct 2009 09:49

CIPLA-NEXT TARGET

Posted by : tara23
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( 0.00 % )

wait for good buying times to come...november may be a golden month to acquire...

30 Oct 2009 09:28

CIPLA-NEXT TARGET

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

DEAR TARA JI,
HI
CAN WE SEE 305-307 LEVELS ON CIPLA TODAY OR IN COMING WEEK, IF NIFTY STARTS CLIMBING AGAIN.

RGDS...

30 Oct 2009 08:54

CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS

Posted by : peddasai
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Though you are right as far as Hajj stats are concerned and its consequences, i advise the traders not to enter at the moment, as the govt stock piled many other drugs which are equally efficient and effective in fighting virus. Further 82 per cent raise is only holding price, otherwise, in the current correction, the price would have been 140 level. watch out for melt to-day...

30 Oct 2009 08:49

CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS

Posted by : tara23
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

a good result from once upon a time best company...

30 Oct 2009 08:41

CIPLA TO LAUNCH AYURVEDA AND HOMEO PRODUCTS

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Cipla to launch ayurveda and homeo products in India

BS Reporter / Mumbai/ Ahmedabad October 30, 2009, 0:09 IST

Pharmaceutical major Cipla India Ltd., under the brand name of its associate, L`amar Natural Products Pvt Ltd, will launch ayurvedic, homeopathic and cosmetic products in India in the coming months. The company, which launched its baby products recently, is in the process of research and development on its ayurvedic product, which includes diabetic capsules and the richest antioxidant, according to Ashok Naik, national sales manager — OTC division Cipla India Ltd.

After exporting various products all these years Cipla, under the brand name of its sister concern, L`amar, is planning to introduce natural products, homeopathic products, cosmetics and perfumes in the Indian market soon. While 20 products will be launched under cosmetics segment by January, 40 and 25 products will be launched under ayurvedic and homeopathic segments, respectively. The company is conducting an R&D on ayurveda diabetes capsules and the richest antioxidant on earth, made out of vegiberries found in China, parts of Tibet, Mongolia and the Himalayas. We are the pioneers of preparing antioxidants out of the vegiberry dryfruit and will launch the products in the next three to four months," Naik said, at a press meet in Ahmedabad to launch the company`s baby care products in Gujarat.

The five baby care products, which include baby oil, powder, soap, lotion and gripe water, will be marketed under platinum marketing, all India business partner for OTC product of Cipla India. The company also plans to launch a cough syrup, pain relief balm, anti-lice lotion and two baby food products in a month.

"The company expects a market share of Rs 40 crore from the over Rs 2,000 crore baby care products market in India and Rs 15 lakh per month from Gujarat. In order to retain its image as a pharma company, Cipla has decided to launch the products under the Rs 1500 crore Paris-headquartered L`amar", Naik added. Currently L`amar exports products to various markets in the Middle East, south East Asia, Africa, Latin America, Australia and Europe.

Cipla recorded an 82 per cent rise in its net profit for the July-September quarter this fiscal.

...

30 Oct 2009 08:37

Cipla to launch ayurveda and homeo products in India -Business Standard

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Pharmaceutical major Cipla India Ltd., under the brand name of its associate, L`amar Natural Products Pvt Ltd, will launch ayurvedic, homeopathic and cosmetic products in India in the coming months. The company, which launched its baby products recently, is in the process of research and development on its ayurvedic product, which includes diabetic capsules and the richest antioxidant, according to Ashok Naik, national sales manager — OTC division Cipla India Ltd.

"After exporting various products all these years Cipla, under the brand name of its sister concern, L`amar, is planning to introduce natural products, homeopathic products, cosmetics and perfumes in the Indian market soon. While 20 products will be launched under cosmetics segment by January, 40 and 25 products will be launched under ayurvedic and homeopathic segments, respectively. The company is conducting an R&D on ayurveda diabetes capsules and the richest antioxidant on earth, made out of vegiberries found in China, parts of Tibet, Mongolia and the Himalayas. We are the pioneers of preparing antioxidants out of the vegiberry dryfruit and will launch the products in the next three to four months," Naik said, at a press meet in Ahmedabad to launch the company`s baby care products in Gujarat.

The five baby care products, which include baby oil, powder, soap, lotion and gripe water, will be marketed under platinum marketing, all India business partner for OTC product of Cipla India. The company also plans to launch a cough syrup, pain relief balm, anti-lice lotion and two baby food products in a month.

"The company expects a market share of Rs 40 crore from the over Rs 2,000 crore baby care products market in India and Rs 15 lakh per month from Gujarat. In order to retain its image as a pharma company, Cipla has decided to launch the products under the Rs 1500 crore Paris-headquartered L`amar", Naik added. Currently L`amar exports products to various markets in the Middle East, south East Asia, Africa, Latin America, Australia and Europe.

Cipla recorded an 82 per cent rise in its net profit for the July-September quarter this fiscal.



...

30 Oct 2009 08:25

CIPLA TO GAIN DURING HAJJ

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Saudis Try to Head Off Swine Flu Fears Before Hajj-Cipla to Gain

By DONALD G. McNEIL Jr.
Published: October 29, 2009
Every year, the single largest gathering on the planet is the annual pilgrimage to Mecca: 2.5 million people from 160 countries packed into a small city in Saudi Arabia for five days.

This year, some will be bringing swine flu.

The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off. They have asked some worshipers, including pregnant women and the elderly, not to make the trip, which is scheduled for the last week of November.

“The hajj is a central ritual of Islam, and our country tries to make it easy for everyone to come,” said Dr. Ziad A. Memish, the country’s assistant deputy minister for preventive medicine. “We’ve said we won’t turn away anyone who arrives at our borders. But we are recommending to other countries whom they should let come.”

Although the Saudis have turned to the World Health Organization and other health agencies for help in previous public health threats to the hajj, this year the Centers for Disease Control and Prevention, the American government’s lead disease-fighting agency, is more deeply involved because it has so much experience with this new flu strain. Consultants for the centers have gone back and forth to Riyadh, flu experts at American medical schools have been called in and the United States Navy’s medical laboratory in Cairo is preparing to help with any complex flu testing that is beyond what Saudi laboratories can do.

While religious pilgrimages feed the souls of those who attend, they often endanger the bodies. There have been several outbreaks of meningitis in Mecca since 1987, and in 2004, Muslim pilgrims spread polio from northern Nigeria across Africa to Saudi Arabia and from there outward to Yemen and Indonesia.

In July 2008, about 200,000 Catholics from all over the world converged on Sydney, Australia, for World Youth Day, attended by the new pope, Benedict XVI, during the Southern Hemisphere’s winter. There was a major flu outbreak, and a Tamiflu-resistant strain of seasonal flu established itself and then spread to the Northern Hemisphere, including to the United States, last winter.

The Saudis reacted because this new strain is the first pandemic flu since 1968. Any new flu carries the risk of gene-swapping that can form mutant viruses, and this one has some swine and avian genes that, before this April, had never been seen in humans. Both the new strain and seasonal flus will be circulating in the world, increasing the risk of flus mixing in Mecca. Also, although the flu infects younger people, the ones most likely to need hospitalization or die if they do get infected are the very young, pregnant women, the sick and the aged.

The hajj offers many opportunities to a virus that spreads through the air and lingers on surfaces: Pilgrims crowded into planes, boats, buses and tent cities; the endless ranks of the faithful praying shoulder to shoulder and touching their hands to the floors around the Kaaba, to handrails as they run between the hills Safa and Marwah, or to cups of water from the Zamzam Well.

A paper published online on Thursday in the journal Science describes many of the obstacles to fighting transmission there. Dr. Memish, the Saudi official, is a co-author with several Centers for Disease Control experts.


The Saudi government has made many preparations, like buying stockpiles of generic Tamiflu from Cipla, an Indian company. The country has 76 health facilities staffed for the hajj, and intensive-care units have been expanded. For pilgrims, all medical care for problems they develop during their visit is free.

...

30 Oct 2009 08:23

buy

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Saudis Try to Head Off Swine Flu Fears Before Hajj-Cipla to Gain

By DONALD G. McNEIL Jr.
Published: October 29, 2009
Every year, the single largest gathering on the planet is the annual pilgrimage to Mecca: 2.5 million people from 160 countries packed into a small city in Saudi Arabia for five days.

This year, some will be bringing swine flu.

The Saudi authorities, fearing that the hajj could turn their holy city into a petri dish for viral mutations and a hub for spreading a new pandemic wave around the world, are working hard to head that off. They have asked some worshipers, including pregnant women and the elderly, not to make the trip, which is scheduled for the last week of November.

“The hajj is a central ritual of Islam, and our country tries to make it easy for everyone to come,” said Dr. Ziad A. Memish, the country’s assistant deputy minister for preventive medicine. “We’ve said we won’t turn away anyone who arrives at our borders. But we are recommending to other countries whom they should let come.”

Although the Saudis have turned to the World Health Organization and other health agencies for help in previous public health threats to the hajj, this year the Centers for Disease Control and Prevention, the American government’s lead disease-fighting agency, is more deeply involved because it has so much experience with this new flu strain. Consultants for the centers have gone back and forth to Riyadh, flu experts at American medical schools have been called in and the United States Navy’s medical laboratory in Cairo is preparing to help with any complex flu testing that is beyond what Saudi laboratories can do.

While religious pilgrimages feed the souls of those who attend, they often endanger the bodies. There have been several outbreaks of meningitis in Mecca since 1987, and in 2004, Muslim pilgrims spread polio from northern Nigeria across Africa to Saudi Arabia and from there outward to Yemen and Indonesia.

In July 2008, about 200,000 Catholics from all over the world converged on Sydney, Australia, for World Youth Day, attended by the new pope, Benedict XVI, during the Southern Hemisphere’s winter. There was a major flu outbreak, and a Tamiflu-resistant strain of seasonal flu established itself and then spread to the Northern Hemisphere, including to the United States, last winter.

The Saudis reacted because this new strain is the first pandemic flu since 1968. Any new flu carries the risk of gene-swapping that can form mutant viruses, and this one has some swine and avian genes that, before this April, had never been seen in humans. Both the new strain and seasonal flus will be circulating in the world, increasing the risk of flus mixing in Mecca. Also, although the flu infects younger people, the ones most likely to need hospitalization or die if they do get infected are the very young, pregnant women, the sick and the aged.

The hajj offers many opportunities to a virus that spreads through the air and lingers on surfaces: Pilgrims crowded into planes, boats, buses and tent cities; the endless ranks of the faithful praying shoulder to shoulder and touching their hands to the floors around the Kaaba, to handrails as they run between the hills Safa and Marwah, or to cups of water from the Zamzam Well.

A paper published online on Thursday in the journal Science describes many of the obstacles to fighting transmission there. Dr. Memish, the Saudi official, is a co-author with several Centers for Disease Control experts.


The Saudi government has made many preparations, like buying stockpiles of generic Tamiflu from Cipla, an Indian company. The country has 76 health facilities staffed for the hajj, and intensive-care units have been expanded. For pilgrims, all medical care for problems they develop during their visit is free.

...

29 Oct 2009 22:12

buy

Posted by : naugtyboy
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

buy tomm for bounceback-thank god us and europe r decent up......

29 Oct 2009 17:54

CIPLA-NEXT TARGET

Posted by : tara23
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

may by mar 10, u may get those levels.....

29 Oct 2009 16:47

CIPLA-NEXT TARGET

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Dear Ji,
Do you think that Cipla will be able to cross 307/308(52 week high) in November?

Your help and advice will be appreciated?

And what would be the target for Cipla by Mar 10.

Warm Rgds!...

29 Oct 2009 16:41

300

Posted by : scorpio76
Price when posted : BSE: Rs 290.80 ( -3.34 % ), NSE: Rs. 289.90 ( -3.61 % )

Dear Sir,
Do you think that Cipla will be able to cross 307/308(52 week high) in November?

Your help and advice will be appreciated?

And sir, what would be the target for Cipla by Mar 10.

Warm Rgds!...